Interestingly, RBCK1 showed significant differential expression between cancer and normal tissues and was significantly related to tumor-infiltrating immune cells, including tumor purity and immune checkpoint molecules such as PD-L1, CTLA-4, LAG-3, and TIGIT in ccRCC (Figure 8C). This evidence concerns the gene RBCK1 and cancer.